One study found that higher CSF MMP-9/TIMP-1 ratios were associated with higher levels of CSF p-tau181 and total tau (t-tau) in individuals who were at high risk of developing AD (as indicated by abnormal AD biomarkers or the presence of APOE ε4) and in AD dementia patients [22]. The gene discussed is MMP9; the disease is Alzheimer disease.